Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status - the TTD-06-01 Spanish Cooperative Group trial

  1. Rivera, F.
  2. Gravalos, C.
  3. Massuti, B.
  4. Puente, J.
  5. Marcuello, E.
  6. Valladares, M.
  7. Gutierrez, V.
  8. Layos, L.
  9. Diaz-Rubio, E.
  10. Aranda, E.
Revista:
EJC SUPPLEMENTS

ISSN: 1359-6349

Ano de publicación: 2009

Volume: 7

Número: 2

Páxinas: 216-216

Congreso: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Tipo: Achega congreso

DOI: 10.1016/S1359-6349(09)70738-4 GOOGLE SCHOLAR

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: WoS